Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | TAS1R3 | Q7RTX0 | 9/20 | 0.54 |
| ▸ | TAS1R1 | Q7RTX1 | 9/20 | 0.54 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | NOS3 | P29474 | 2/20 | 0.47 |
| ▸ | NOS1 | P29475 | 2/20 | 0.47 |
| ▸ | NOS2 | P35228 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5812880 | 1.00 | ALDH1A1 (0.64) | ALDH1A1TAS1R3TAS1R1BIRC2POLB | |
| SCHEMBL11316551 | 1.00 | ALDH1A1 (0.64) | ALDH1A1TAS1R3TAS1R1BIRC2POLB | |
| SCHEMBL24178319 | 0.93 | BIRC2 (0.57) | ALDH1A1TAS1R3TAS1R1BIRC2POLB | |
| SCHEMBL5808681 | 0.84 | ALDH1A1 (0.60) | ALDH1A1TAS1R3TAS1R1BIRC2POLB | |
| SCHEMBL21488669 | 0.84 | ALDH1A1 (0.60) | ALDH1A1TAS1R3TAS1R1BIRC2POLB | |
| SCHEMBL5813379 | 0.84 | ALDH1A1 (0.60) | ALDH1A1TAS1R3TAS1R1BIRC2POLB | |
| SCHEMBL5813383 | 0.84 | ALDH1A1 (0.60) | ALDH1A1TAS1R3TAS1R1BIRC2POLB | |
| SCHEMBL10795132 | 0.84 | ALDH1A1 (0.60) | ALDH1A1TAS1R3TAS1R1BIRC2POLB | |
| SCHEMBL15435453 | 0.84 | ALDH1A1 (0.60) | ALDH1A1TAS1R3TAS1R1BIRC2POLB | |
| SCHEMBL5808683 | 0.84 | ALDH1A1 (0.60) | ALDH1A1TAS1R3TAS1R1BIRC2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006119283-A2 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J (US) | 2006-11-09 | — | — | WO | claimed |
| US-20060251597-A1 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J | 2006-11-09 | — | — | US | claimed |
| US-4259441-A | Process for resolving D, L-leucine | ETHYL CORPORATION (US) | 1981-03-31 | — | — | US | claimed |
| US-11008287-B2 | Sulfoxyalkyl organonitro and related compounds and pharmaceutical compounds for use in medicine | EPICENTRX, INC. (US) | 2021-05-18 | — | — | US | disclosed |
| US-20200157047-A1 | SULFOXYALKYL ORGANONITRO AND RELATED COMPOUNDS AND PHARMACEUTICAL COMPOUNDS FOR USE IN MEDICINE | EPICENTRX, INC. | 2020-05-21 | — | — | US | disclosed |
| US-10414864-B2 | Degradable amino acid-based poly (ester urea) copolymer adhesives | THE UNIVERSITY OF AKRON (US) | 2019-09-17 | — | — | US | disclosed |
| US-20170210852-A1 | DEGRADABLE AMINO ACID-BASED POLY (ESTER UREA) COPOLYMER ADHESIVES | THE UNIVERSITY OF AKRON (US) | 2017-07-27 | — | — | US | disclosed |
| US-9468625-B2 | Organonitro thioether compounds and medical uses thereof | EPICENTRX, INC. (US) | 2016-10-18 | — | — | US | disclosed |
| US-20160081981-A1 | ORGANONITRO THIOETHER COMPOUNDS AND MEDICAL USES THEREOF | RADIORX, INC. | 2016-03-24 | — | — | US | disclosed |
| US-9139519-B2 | Organonitro thioether compounds and medical uses thereof | EPICENTRX, INC. (US) | 2015-09-22 | — | — | US | disclosed |
| US-20140349988-A1 | ORGANONITRO THIOETHER COMPOUNDS AND MEDICAL USES THEREOF | RADIORX, INC. (US) | 2014-11-27 | — | — | US | disclosed |
| US-5532395-A | HYDROGENATION CATALYSTS ) | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-07-02 | — | — | US | disclosed |
| US-5386061-A | Reacting a bis(primary phosphine in the presence of a strong base with a cyclic sulfate; cyclization | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-01-31 | — | — | US | disclosed |
| US-5329015-A | Catalysts for stereospecific reactions | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-07-12 | — | — | US | disclosed |
| EP-0592552-A1 | CHIRAL PHOSPHOLANES VIA CHIRAL 1,4-DIOL CYCLIC SULFATES. | DU PONT (US) | 1994-04-20 | — | — | EP | disclosed |
| WO-1993001199-A1 | CHIRAL PHOSPHOLANES VIA CHIRAL 1,4-DIOL CYCLIC SULFATES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-01-21 | — | — | WO | disclosed |
| US-5171892-A | Chiral phospholanes via chiral 1,4-diol cyclic sulfates | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-12-15 | — | — | US | disclosed |
| US-4670395-A | Enantioselective hydrolysis of N-acylamino acid esters using a combined enzyme system | THE STANDARD OIL COMPANY (US) | 1987-06-02 | — | — | US | disclosed |
| US-4259441-A | Process for resolving D, L-leucine | ETHYL CORPORATION (US) | 1981-03-31 | — | — | US | disclosed |
| US-RE29843-E | Substituted thiazoles and flavoring processes and products produced thereby | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170210852-A1 | DEGRADABLE AMINO ACID-BASED POLY (ESTER UREA) COPOLYMER ADHESIVES | PNMT, UBE3A, PCNA | ALDH1A1 676/4885TAS1R3 3044/4885TAS1R1 3077/4885 |
| US-11008287-B2 | Sulfoxyalkyl organonitro and related compounds and pharmaceutical compounds for use in medicine | AS3MT, SLC10A6, SLCO1B3 | ALDH1A1 2681/4885TAS1R3 479/4885TAS1R1 825/4885 |
| US-20200157047-A1 | SULFOXYALKYL ORGANONITRO AND RELATED COMPOUNDS AND PHARMACEUTICAL COMPOUNDS FOR USE IN MEDICINE | AS3MT, SLC10A6, SLCO1B3 | ALDH1A1 2681/4885TAS1R3 479/4885TAS1R1 825/4885 |
| US-20140349988-A1 | ORGANONITRO THIOETHER COMPOUNDS AND MEDICAL USES THEREOF | SLC22A8, SLCO2A1, SLCO2B1 | ALDH1A1 1453/4885TAS1R3 801/4885TAS1R1 1177/4885 |
| US-20160081981-A1 | ORGANONITRO THIOETHER COMPOUNDS AND MEDICAL USES THEREOF | SLC22A8, XPOT, NPM1 | ALDH1A1 2447/4885TAS1R3 555/4885TAS1R1 1229/4885 |
| US-10414864-B2 | Degradable amino acid-based poly (ester urea) copolymer adhesives | PNMT, UBE3A, PCNA | ALDH1A1 676/4885TAS1R3 3044/4885TAS1R1 3077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.